In addition, our experiments revealed that the suppressive impact of sh-ELAVL1 on the glycolytic ability of nasopharyngeal carcinoma cells was reversed upon subsequent overexpression of HMGB3. This evidence concerns the gene HMGB3 and nasopharyngeal carcinoma.